Attitudes of Patients With Cancer About Personalized Medicine and Somatic Genetic Testing-Reference-Cited by-同舟云学术

Attitudes of Patients With Cancer About Personalized Medicine and Somatic Genetic Testing

Published:2012-11 Issue:6 Volume:8 Page:329-335
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Gray Stacy W.¹,Hicks-Courant Katherine¹,Lathan Christopher S.¹,Garraway Levi¹,Park Elyse R.¹,Weeks Jane C.¹

Affiliation:

1. Dana-Farber Cancer Institute; Harvard Medical School; and Massachusetts General Hospital, Boston, MA

Abstract

Patients have relayed misunderstandings about somatic testing and a reluctance to have full sequencing; oncologists must consider how they present testing to patients so concerns over discrimination and psychological harm do not hinder test uptake.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2012.000626

Reference38 articles.

1. All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

2. Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A

3. Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation

4. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

5. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system;Implementation Science;2024-08-19

2. Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery;JCO Precision Oncology;2024-08

3. Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing;Pathology;2024-06

4. Survey of Patients' and Physicians' Attitudes Toward Explanations by Physicians at Initial Treatment Selection for Advanced or Recurrent Non-small Cell Lung Cancer: Gaps Observed Between Patients' Wishes and Physicians' Perceptions;Haigan;2024-04-20

5. Oncologists’ perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients;BMC Cancer;2024-04-02